SERPINB13 is a novel RUNX1 target gene

被引:6
|
作者
Boyapati, Anita [2 ]
Ren, Bing
Zhang, Dong-Er [1 ,2 ,3 ]
机构
[1] Univ Calif San Diego, Moores UCSD Canc Ctr, Ludwig Inst Canc Res, La Jolla, CA 92093 USA
[2] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[3] Univ Calif San Diego, Moores Canc Ctr, Dept Pathol & Div Biol, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
RUNX; Transcription; SERPINB13; Chromatin immunoprecipitation; CATHEPSIN-K; 21; TRANSLOCATION; DNA-BINDING; PROMOTER; HEADPIN; AML1; IDENTIFICATION; PROTEINS; CLONING; PURIFICATION;
D O I
10.1016/j.bbrc.2011.06.107
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RUNX1 is a critical transcription factor during embryogenesis and neoplastic disease. To identify novel transcriptional targets of RUNX1 in the context of chromatin, we performed genome wide location analysis (ChIP-on-chip). Here we report that SERPINB13, a gene downregulated in head and neck cancers, is a novel RUNX1transcriptional target. RUNX1 binds the SERPINB13 promoter in chromatin to repress its transcription. Mutation of either RUNX1 binding site in the SERPINB13 promoter increased the activity of the promoter. Finally, overexpression of RUNX1 and concomitant decrease in SERPINB13 expression led to increased activity of cathepsin K, an enzyme inhibited by SERPINB13. These data demonstrate that RUNX1 is an important regulator of SERPINB13 and cathepsin K activity. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 50 条
  • [1] RUNX1 as a Novel Molecular Target for Breast Cancer
    Ariffin, Nur Syamimi
    CLINICAL BREAST CANCER, 2022, 22 (06) : 499 - 506
  • [2] Examination of the Humanized Antibody to SerpinB13 in Autoimmune Diabetes
    Altekreeti, Marwah
    Avdulov, Svetlana V.
    Szepietowska, Barbara
    Meng, Shawn Z.
    Kryvalap, Yury
    Czyzyk, Jan
    DIABETES, 2024, 73
  • [3] SerpinB13 antibodies promote β cell development and resistance to type 1 diabetes
    Kryvalap, Yury
    Jiang, Matthew L.
    Kryvalap, Nadzeya
    Hendrickson, Cole
    Czyzyk, Jan
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (588)
  • [4] The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1
    Qadi, Abeer A.
    Taberlay, Phillippa C.
    Phillips, Jessica L.
    Young, Arabella
    West, Alison C.
    Brettingham-Moore, Kate H.
    Dickinson, Joanne L.
    Holloway, Adele F.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (01) : 49 - 58
  • [5] Rasip 1 is a RUNX1 target gene and promotes migration of NSCLC cells
    Chen, Yan
    Zhang, Lin
    Liu, Lei
    Sun, Shixiu
    Zhao, Xuyang
    Wang, Yueyuan
    Zhang, Yujie
    Du, Jun
    Gu, Luo
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4537 - 4552
  • [6] SerpinB13 Regulates Proliferation and Cell Survival in Beta Cells
    Kryvalap, Yury
    Czyzyk, Jan
    DIABETES, 2024, 73
  • [7] Human Autoantibodies to SerpinB13 Are Both Protective and Functional in Type 1 Diabetes
    Kryvalap, Yury
    Czyzyk, Jan
    DIABETES, 2020, 69
  • [8] Novel RUNX1 targeted therapy for AML expressing mutant RUNX1
    Mill, Christopher P.
    DiNardo, Courtney D.
    Fiskus, Warren
    Saenz, Dyana T.
    Nowak, Agnieszka J.
    Sun, Baohua
    Saenz, David N.
    Kornblau, Steven M.
    Bhalla, Kapil N.
    CANCER RESEARCH, 2018, 78 (13)
  • [9] C11orf21, a novel RUNX1 target gene, is down-regulated by RUNX1-ETO
    Matsumoto, Akifumi
    Yoshida, Tatsushi
    Shima, Takahiro
    Yamasaki, Kenta
    Tadagaki, Kenjiro
    Kondo, Noriko
    Kuwahara, Yasumichi
    Zhang, Dong-Er
    Okuda, Tsukasa
    BBA ADVANCES, 2022, 2
  • [10] SCL and RUNX1 regulate RUNX1 gene expression by association to RUNX1-P1 promoter
    Gutierrez, S.
    Martinez, M.
    FEBS JOURNAL, 2014, 281 : 689 - 689